Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,533
archived clinical trials in
Kidney Cancer

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated:  10/20/2015
Virginia Commonwealth University
2269
mi
from 91732
Richmond, VA
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated: 10/20/2015
Virginia Commonwealth University
2269
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated:  10/20/2015
Carilion Clinic Children's Hospital
2133
mi
from 91732
Roanoke, VA
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated: 10/20/2015
Carilion Clinic Children's Hospital
2133
mi
from 91732
Roanoke, VA
Click here to add this to my saved trials
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated:  10/20/2015
Seattle Children's Hospital
964
mi
from 91732
Seattle, WA
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated: 10/20/2015
Seattle Children's Hospital
964
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated:  10/20/2015
Providence Sacred Heart Medical Center & Children's Hospital
939
mi
from 91732
Spokane, WA
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated: 10/20/2015
Providence Sacred Heart Medical Center & Children's Hospital
939
mi
from 91732
Spokane, WA
Click here to add this to my saved trials
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated:  10/20/2015
Mary Bridge Children's Hospital and Health Center
939
mi
from 91732
Tacoma, WA
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated: 10/20/2015
Mary Bridge Children's Hospital and Health Center
939
mi
from 91732
Tacoma, WA
Click here to add this to my saved trials
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated:  10/20/2015
Madigan Army Medical Center
941
mi
from 91732
Tacoma, WA
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated: 10/20/2015
Madigan Army Medical Center
941
mi
from 91732
Tacoma, WA
Click here to add this to my saved trials
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated:  10/20/2015
West Virginia University Charleston
2037
mi
from 91732
Charleston, WV
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated: 10/20/2015
West Virginia University Charleston
2037
mi
from 91732
Charleston, WV
Click here to add this to my saved trials
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated:  10/20/2015
University of Wisconsin Hospital and Clinics
1654
mi
from 91732
Madison, WI
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated: 10/20/2015
University of Wisconsin Hospital and Clinics
1654
mi
from 91732
Madison, WI
Click here to add this to my saved trials
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated:  10/20/2015
Marshfield Clinic
1646
mi
from 91732
Marshfield, WI
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated: 10/20/2015
Marshfield Clinic
1646
mi
from 91732
Marshfield, WI
Click here to add this to my saved trials
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated:  10/20/2015
Midwest Children's Cancer Center
1729
mi
from 91732
Milwaukee, WI
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated: 10/20/2015
Midwest Children's Cancer Center
1729
mi
from 91732
Milwaukee, WI
Click here to add this to my saved trials
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated:  10/20/2015
Sydney Children's Hospital
7513
mi
from 91732
Randwick,
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Status: Enrolling
Updated: 10/20/2015
Sydney Children's Hospital
7513
mi
from 91732
Randwick,
Click here to add this to my saved trials
Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery
Biomarkers of Tumor Angiogenesis and Response to Sunitinib Maleate in Renal Cell Carcinoma
Status: Enrolling
Updated:  10/21/2015
Hollings Cancer Center at Medical University of South Carolina
2184
mi
from 91732
Charleston, SC
Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery
Biomarkers of Tumor Angiogenesis and Response to Sunitinib Maleate in Renal Cell Carcinoma
Status: Enrolling
Updated: 10/21/2015
Hollings Cancer Center at Medical University of South Carolina
2184
mi
from 91732
Charleston, SC
Click here to add this to my saved trials
Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer
A Phase I/II Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Combination With Isotretinoin (13-cis Retinoic Acid, 13-CRA) in the Treatment of Patients With Advanced Renal Cell Carcinoma
Status: Enrolling
Updated:  10/22/2015
Montefiore Medical Center - Moses Campus
2439
mi
from 91732
Bronx, NY
Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer
A Phase I/II Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Combination With Isotretinoin (13-cis Retinoic Acid, 13-CRA) in the Treatment of Patients With Advanced Renal Cell Carcinoma
Status: Enrolling
Updated: 10/22/2015
Montefiore Medical Center - Moses Campus
2439
mi
from 91732
Bronx, NY
Click here to add this to my saved trials
Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer
A Phase I/II Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Combination With Isotretinoin (13-cis Retinoic Acid, 13-CRA) in the Treatment of Patients With Advanced Renal Cell Carcinoma
Status: Enrolling
Updated:  10/22/2015
Weill Medical College of Cornell University
2434
mi
from 91732
New York, NY
Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer
A Phase I/II Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Combination With Isotretinoin (13-cis Retinoic Acid, 13-CRA) in the Treatment of Patients With Advanced Renal Cell Carcinoma
Status: Enrolling
Updated: 10/22/2015
Weill Medical College of Cornell University
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors
Phase II Study of Arsenic Trioxide in Neuroblastoma and Other Pediatric Solid Tumors
Status: Enrolling
Updated:  10/22/2015
Memorial Sloan Kettering Cancer Center
2434
mi
from 91732
New York, NY
Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors
Phase II Study of Arsenic Trioxide in Neuroblastoma and Other Pediatric Solid Tumors
Status: Enrolling
Updated: 10/22/2015
Memorial Sloan Kettering Cancer Center
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer
Phase II Study of Sunitinib in Patients With Metastatic Papillary Renal Cell Carcinoma
Status: Enrolling
Updated:  10/26/2015
Memorial Sloan Kettering Cancer Center
2434
mi
from 91732
New York, NY
Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer
Phase II Study of Sunitinib in Patients With Metastatic Papillary Renal Cell Carcinoma
Status: Enrolling
Updated: 10/26/2015
Memorial Sloan Kettering Cancer Center
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
Bortezomib in Treating Patients With Metastatic Kidney Cancer
A Phase II Study of Bortezomib (Velcade ) Administered as a Single Agent in Metastatic Non-Clear Cell Renal Cell Carcinoma (RCC) Patients
Status: Enrolling
Updated:  10/28/2015
Jonsson Comprehensive Cancer Center at UCLA
24
mi
from 91732
Los Angeles, CA
Bortezomib in Treating Patients With Metastatic Kidney Cancer
A Phase II Study of Bortezomib (Velcade ) Administered as a Single Agent in Metastatic Non-Clear Cell Renal Cell Carcinoma (RCC) Patients
Status: Enrolling
Updated: 10/28/2015
Jonsson Comprehensive Cancer Center at UCLA
24
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC)
Phase I Trial of Sunitinib Plus Temsirolimus in Patients With Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  11/16/2015
UT MD Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC)
Phase I Trial of Sunitinib Plus Temsirolimus in Patients With Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 11/16/2015
UT MD Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma
A Phase II Study of SU11248 (Sunitinib) in Patients With Renal Cell Carcinoma and Melanoma Metastatic to the Brain
Status: Enrolling
Updated:  11/24/2015
Memorial Sloan Kettering Cancer Center
2434
mi
from 91732
New York, NY
Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma
A Phase II Study of SU11248 (Sunitinib) in Patients With Renal Cell Carcinoma and Melanoma Metastatic to the Brain
Status: Enrolling
Updated: 11/24/2015
Memorial Sloan Kettering Cancer Center
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer
Phase IA/IB Trial of Modulation of the Biological Response to Interleukin-2 (IL-2) With Bryostatin 1 (BRYO; NSC 339555)
Status: Enrolling
Updated:  12/10/2015
Norris Cotton Cancer Center
2515
mi
from 91732
Lebanon, NH
Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer
Phase IA/IB Trial of Modulation of the Biological Response to Interleukin-2 (IL-2) With Bryostatin 1 (BRYO; NSC 339555)
Status: Enrolling
Updated: 12/10/2015
Norris Cotton Cancer Center
2515
mi
from 91732
Lebanon, NH
Click here to add this to my saved trials
Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer
Phase IA/IB Trial of Modulation of the Biological Response to Interleukin-2 (IL-2) With Bryostatin 1 (BRYO; NSC 339555)
Status: Enrolling
Updated:  12/10/2015
Massey Cancer Center
2269
mi
from 91732
Richmond, VA
Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer
Phase IA/IB Trial of Modulation of the Biological Response to Interleukin-2 (IL-2) With Bryostatin 1 (BRYO; NSC 339555)
Status: Enrolling
Updated: 12/10/2015
Massey Cancer Center
2269
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast
Evaluation of Renal Masses Using Ultrasound Intravenous Microbubble Contrast
Status: Enrolling
Updated:  12/23/2015
Memorial Sloan Kettering Cancer Center
2434
mi
from 91732
New York, NY
Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast
Evaluation of Renal Masses Using Ultrasound Intravenous Microbubble Contrast
Status: Enrolling
Updated: 12/23/2015
Memorial Sloan Kettering Cancer Center
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
University of Alabama at Birmingham, Comprehensive Cancer Center
1784
mi
from 91732
Birmingham, AL
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
University of Alabama at Birmingham, Comprehensive Cancer Center
1784
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
Jonsson Comprehensive Cancer Center at UCLA
24
mi
from 91732
Los Angeles, CA
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
Jonsson Comprehensive Cancer Center at UCLA
24
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
Children's Hospital of Orange County
21
mi
from 91732
Orange, CA
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
Children's Hospital of Orange County
21
mi
from 91732
Orange, CA
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
Stanford Comprehensive Cancer Center at Stanford University Medical Center
30
mi
from 91732
Stanford, CA
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
Stanford Comprehensive Cancer Center at Stanford University Medical Center
30
mi
from 91732
Stanford, CA
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
Childrens National Medical Center
2281
mi
from 91732
Washington,
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
Childrens National Medical Center
2281
mi
from 91732
Washington,
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
University of Florida Shands Cancer Center
2104
mi
from 91732
Gainesville, FL
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
University of Florida Shands Cancer Center
2104
mi
from 91732
Gainesville, FL
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
Nemours Children's Clinic
2130
mi
from 91732
Jacksonville, FL
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
Nemours Children's Clinic
2130
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
University of Miami, Sylvester Comprehensive Cancer Center
2320
mi
from 91732
Miami, FL
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
University of Miami, Sylvester Comprehensive Cancer Center
2320
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
All Children's Hospital
2130
mi
from 91732
St. Petersburg, FL
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
All Children's Hospital
2130
mi
from 91732
St. Petersburg, FL
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
St. Joseph's Cancer Institute at St. Joseph's Hospital
2133
mi
from 91732
Tampa, FL
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
St. Joseph's Cancer Institute at St. Joseph's Hospital
2133
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
Winship Cancer Institute at Emory University
1922
mi
from 91732
Atlanta, GA
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
Winship Cancer Institute at Emory University
1922
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
Cancer Research Center of Hawaii
2572
mi
from 91732
Honolulu, HI
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
Cancer Research Center of Hawaii
2572
mi
from 91732
Honolulu, HI
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
Indiana University Cancer Center
1792
mi
from 91732
Indianapolis, IN
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
Indiana University Cancer Center
1792
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
Holden Comprehensive Cancer Center at University of Iowa
1528
mi
from 91732
Iowa City, IA
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
Holden Comprehensive Cancer Center at University of Iowa
1528
mi
from 91732
Iowa City, IA
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
1332
mi
from 91732
Kansas City, KA
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
1332
mi
from 91732
Kansas City, KA
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
Children's Hospital of New Orleans
1653
mi
from 91732
New Orleans, LA
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
Children's Hospital of New Orleans
1653
mi
from 91732
New Orleans, LA
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2302
mi
from 91732
Baltimore, MD
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2302
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
Floating Hospital for Children in Boston
2578
mi
from 91732
Boston, MA
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
Floating Hospital for Children in Boston
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
CS Mott Children's Hospital, University of Michigan
1932
mi
from 91732
Ann Arbor, MI
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
CS Mott Children's Hospital, University of Michigan
1932
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
Spectrum Health Hospital - Butterworth Campus
1840
mi
from 91732
Grand Rapids, MI
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
Spectrum Health Hospital - Butterworth Campus
1840
mi
from 91732
Grand Rapids, MI
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
Children's Hospitals and Clinics - Minneapolis
1509
mi
from 91732
Minneapolis, MN
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
Children's Hospitals and Clinics - Minneapolis
1509
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
University of Minnesota Medical Center & Children's Hospital - Fairview
1511
mi
from 91732
Minneapolis, MN
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
University of Minnesota Medical Center & Children's Hospital - Fairview
1511
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
University of Mississippi Medical Center
1609
mi
from 91732
Jackson, MS
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
University of Mississippi Medical Center
1609
mi
from 91732
Jackson, MS
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
Siteman Cancer Center at Barnes-Jewish Hospital
1570
mi
from 91732
St. Louis, MO
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
Siteman Cancer Center at Barnes-Jewish Hospital
1570
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
Albert Einstein Cancer Center at Albert Einstein College of Medicine
2440
mi
from 91732
Bronx, NY
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
Albert Einstein Cancer Center at Albert Einstein College of Medicine
2440
mi
from 91732
Bronx, NY
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
Schneider Children's Hospital
2448
mi
from 91732
New Hyde Park, NY
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
Schneider Children's Hospital
2448
mi
from 91732
New Hyde Park, NY
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
Herbert Irving Comprehensive Cancer Center of Columbia University
2432
mi
from 91732
New York, NY
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
Herbert Irving Comprehensive Cancer Center of Columbia University
2432
mi
from 91732
New York, NY
Click here to add this to my saved trials
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  1/5/2016
SUNY Upstate Medical University Hospital
2320
mi
from 91732
Syracuse, NY
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 1/5/2016
SUNY Upstate Medical University Hospital
2320
mi
from 91732
Syracuse, NY
Click here to add this to my saved trials